Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Goh, KL; Parasakthi, N; Chuah, SY; Toetsch, M.
Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori - a randomized, double-blind comparison of a three times daily and twice daily regimen
EUR J GASTROENTEROL HEPATOL. 1997; 9(11): 1091-1095. Doi: 10.1097/00042737-199711000-00012
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Tötsch Martin
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Objectives: To determine the efficacy of a three times daily (t. i. d.) versus a twice daily (b. i. d.) regimen of combination amoxycillin and metronidazole and famotidine in the eradication of Helicobacter pylori and the influence of metronidazole resistance on the outcome of treatment. Patients: Patients selected had unequivocal evidence of H. pylori infection based on the urease test, culture and histology and had either peptic ulcer disease or non-ulcer dyspepsia. Design: The study was a comparative and double-blind study and patients were randomized to receive either amoxycillin 750 mg t. i. d. and metronidazole 500 mg t. i. d. for 12 days or amoxycillin 1000 mg b. i. d. and metronidazole 500 mg b. i. d. for 12 days. Both groups also received famotidine 40 mg for 6 weeks. Main outcome measure: Patients were assessed for successful eradication, defined as absence of bacteria in all tests, at least 4 weeks after completion of antibiotic therapy by repeat gastroscopy. Results: One hundred and twenty-nine patients were recruited for the study. Two patients defaulted follow-up, two patients were withdrawn from the study and six patients were found to be non-compliant with medications. The eradication rates of the t. i. d. regimen was higher than the b. i. d. regimen (per protocol (PP) analysis: 83.3% (50/60) vs. 76.3% (45/59), P = 0.337; intention-to-treat (ITT) analysis: 78.5% (51/65) vs. 75.0% (48/64), P = 0.642). Seventy-five patients had pre-treatment cultures checked for metronidazole resistance, 33 (44.0%) were found to be resistant. Acquired resistance occurred in 3/40 (7.5%) patients. Eradication rates of metronidazole-sensitive and metronidazole-resistant patients: t. i. d. regimen - 100% (17/17) and 88.2% (15/17), b. i. d. regimen -19/21 (90.5%) and 11/15 (73.3%). Side effects were reported in up to 70% of patients but were mild and tolerable in the majority. Two patients were withdrawn from the study because of a fixed drug eruption in one and generalized macular rash in the other. Conclusion: Combination amoxycillin and metronidazole is effective in eradicating H. pylori. There was a tendency for the t. i. d. regimen to be better than the b. i. d. regimen and for metronidazole-resistant infections to be associated with a lower eradication rate but these differences did not reach statistical significance.
Find related publications in this database (using NLM MeSH Indexing): Adolescent -; Adult -; Aged -; Amoxicillin - administration and dosage Amoxicillin - adverse effects; Antitrichomonal Agents - administration and dosage Antitrichomonal Agents - adverse effects; Double-Blind Method -; Drug Resistance, Microbial -; Drug Therapy, Combination - adverse effects Drug Therapy, Combination - therapeutic use; Famotidine - administration and dosage Famotidine - adverse effects; Female -; Helicobacter Infections - drug therapy; Helicobacter pylori - drug effects Helicobacter pylori - isolation and purification; Histamine H2 Antagonists - administration and dosage Histamine H2 Antagonists - adverse effects; Humans -; Male -; Metronidazole - administration and dosage Metronidazole - adverse effects; Middle Aged -; Penicillins - administration and dosage Penicillins - adverse effects; Treatment Outcome -
Find related publications in this database (Keywords): Helicobacter pylori; eradication; amoxycillin; metronidazole; bacterial resistance